MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients.

Brian G HuntChristina A WickerJennifer R BournElyse E LowerVinita TakiarSusan E Waltz

Published in: Breast cancer research and treatment (2020)

MST1R expression has prognostic value in breast cancer with respect to survival and metastatic progression. MST1R expression is not associated with tumor stage, nodal status, or subtype.

Keyphrases

poor prognosis
small cell lung cancer
squamous cell carcinoma
long non coding rna
free survival
childhood cancer